Retraction: Precision Brain Tumour Diagnosis with Convolutional Recurrent Attention Networks. OBM Neurobiology 2026; 10(3): 351
OBM Neurobiology Editorial Office 
-
LIDSEN Publishing Inc., 2000 Auburn Drive, One Chagrin Highlands, Suite 200, Beachwood, OH, USA
Received: October 25, 2026 | Accepted: October 25, 2026 | Published: October 25, 2026
OBM Neurobiology 2026, Volume 10, Issue 4, doi:10.21926/obm.neurobiol.2604357
Recommended citation: OBM Neurobiology Editorial Office. Retraction: Precision Brain Tumour Diagnosis with Convolutional Recurrent Attention Networks. OBM Neurobiology 2026; 10(3): 351. OBM Neurobiology 2026; 10(4): 357; doi:10.21926/obm.neurobiol.2604357.
© 2026 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.
Retraction of the article:
S.L. Jany Shabu, L. Lakshmanan, J. Refonaa, S. Dhamodaran, Aimin Li, Saurav Mallik Precision Brain Tumour Diagnosis with Convolutional Recurrent Attention Networks. OBM Neurobiology 2026; 10(3): 351; doi: 10.21926/obm.neurobiol.2603351
Following publication, the editorial office received a request from the first author to revise the article, accompanied by a list of proposed changes of unclear origin and a revised version of the accepted manuscript. The editorial office contacted the authors to clarify the source of the proposed changes and confirm that all authors had agreed to them. The authors were also informed that the requested revisions would substantially alter the article’s content.
Nevertheless, the authors maintained that the changes had been prepared by their team and requested extensive revisions to the published article. After consulting the academic editor responsible for the article, the editorial office determined that the authors’ actions raised concerns about the reliability of the published work and therefore decided to retract the article. All authors were notified of this decision, but none responded.
OBM Neurobiology is a member of the Committee on Publication Ethics (COPE), follows the COPE Guidance, and conscientiously implements publishing ethics requirements and related policies.
